March 27 (Reuters) - Resverlogix Corp RVX.TO :
* RESVERLOGIX ANNOUNCES NINTH POSITIVE DATA SAFETY MONITORING BOARD RECOMMENDATION FOR PHASE 3 STUDY OF APABETALONE
* RESVERLOGIX CORP - DSMB REVIEWED AVAILABLE SAFETY DATA AND COMMENTED THAT NO SAFETY CONCERNS WERE IDENTIFIED
* RESVERLOGIX CORP - BETONMACE TRIAL IS CURRENTLY EXPECTED TO BE COMPLETED WITHIN FIRST HALF OF CALENDAR 2019